Prevention of PKG1α oxidation augments cardioprotection in the stressed heart

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Oxidative Stress Research

Background:

• The cyclic GMP-dependent protein kinase-1α (PKG1α) pathway is crucial for cardiovascular homeostasis.
• Oxidative stress is a known factor in heart disease progression and can affect signaling pathways.
• PKG1α can undergo oxidation, but its role in myocardial regulation under disease conditions was unclear.

Purpose of the Study:

• To investigate the impact of PKG1α oxidation on myocardial regulation in heart disease.
• To determine if PKG1α oxidation contributes to adverse cardiac remodeling.
• To explore the potential of maintaining PKG1α in its reduced form for cardioprotection.

Main Methods:

• Assessed PKG1α oxidation in human heart disease patients and rodent models.
• Utilized a redox-dead PKG1α mutant (PKG1α(C42S)) to study the effects of oxidation.
• Evaluated cardiac function, histology, and molecular markers under stress conditions.
• Examined the subcellular localization of oxidized versus reduced PKG1α.
• Investigated the interaction of PKG1α with TRPC6 channels.

Main Results:

• PKG1α was found to be oxidized in patients and models of heart disease.
• Myocardial PKG1α oxidation correlated with adverse cardiac remodeling following pressure overload or Gq agonist stimulation.
• Hearts expressing PKG1α(C42S) showed better adaptation to stress compared to controls.
• Oxidized PKG1α localized to the cytosol, while reduced PKG1α(C42S) localized to the plasma membrane.
• Reduced PKG1α enhanced TRPC6 suppression, leading to improved antihypertrophic signaling.

Conclusions:

• Myocardial PKG1α oxidation hinders beneficial responses to pathological stress.
• PKG1α oxidation may explain variable clinical responses to PKG1α pathway activation in heart disease.
• Maintaining PKG1α in its reduced state could optimize its cardioprotective effects.